[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652209":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":10,"responsibleParty":25,"collaborators":10,"id":29,"slug":30,"hasResults":31,"nctId":32,"briefTitle":33,"officialTitle":34,"acronym":10,"eligibilityCriteria":35,"healthyVolunteers":31,"sex":36,"minAge":37,"maxAge":10,"enrollmentInfo":38,"targetDuration":10,"studyType":41,"phases":10,"briefSummary":42,"conditions":43,"keywords":45,"overallStatus":49,"whyStopped":10,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":10},{"fullName":5,"class":6},"Hacettepe University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with Hip Osteoarthritis",null,"Adults with clinically and\u002For radiographically diagnosed hip osteoarthritis who are scheduled to undergo primary total hip arthroplasty. Participants will complete the Turkish version of the Hip Disability and Osteoarthritis Outcome Score-12 (HOOS-12) and the Short Form-12 Health Survey (SF-12) before surgery. A subset of clinically stable participants will complete the HOOS-12 again after 7 days for test-retest reliability assessment. Participants will also complete the HOOS-12 and SF-12 three months after surgery to evaluate responsiveness.",[13],"Other: Patient-Reported Outcome Assessment",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Patient-Reported Outcome Assessment","Participants will complete the Turkish version of the Hip Disability and Osteoarthritis Outcome Score-12 (HOOS-12) and the Short Form-12 Health Survey (SF-12) at predefined assessment time points. No therapeutic intervention will be assigned or administered as part of this observational study. Primary total hip arthroplasty will be performed as part of routine clinical care and will not be assigned by the investigators.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Nazli Cigercioglu Assoc. Prof.","CONTACT","+90 541 290 32 93","nazlicigercioglu@gmail.com",{"type":26,"investigatorFullName":27,"investigatorTitle":28,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Nazli Cigercioglu","Assoc. Prof.","100652209","turkish-validation-of-the-hoos-12-100652209",false,"NCT07770971","Turkish Validation of the HOOS-12","Turkish Cross-cultural Adaptation, Validity, Reliability, and Responsiveness of the Hip Disability and Osteoarthritis Outcome Score-12 (HOOS-12) in Patients With Hip Osteoarthritis","Inclusion Criteria:\n\n* Age 18 years or older.\n* Native Turkish speaker or able to read and understand Turkish fluently.\n* Diagnosed with primary hip osteoarthritis based on clinical and radiographic evaluation.\n* Scheduled to undergo primary total hip arthroplasty.\n* Able to complete the study questionnaires independently or with standardized assistance.\n* Clinically stable during the test-retest period.\n* Willing to participate in the study and provide written informed consent.\n\nExclusion Criteria:\n\n* Previous total hip arthroplasty on the affected side.\n* Scheduled for revision hip arthroplasty.\n* Hip arthroplasty indicated for conditions other than primary hip osteoarthritis, including hip fracture, inflammatory arthritis, avascular necrosis, congenital hip disorders, or malignancy.\n* History of major lower-extremity surgery within the previous six months.\n* Neurological or neuromuscular disorders that may substantially affect mobility or lower-extremity function.\n* Severe cognitive impairment, psychiatric disorder, or communication difficulty that prevents reliable questionnaire completion.\n* Severe visual or hearing impairment that prevents completion of the assessment procedures.\n* Presence of another acute musculoskeletal condition that substantially affects pain or physical function.\n* Any therapeutic intervention, significant change in medication, acute clinical deterioration, or surgery occurring between the baseline and test-retest assessments.\n* Incomplete questionnaire data or inability to complete the planned follow-up assessments.","ALL","18 Years",{"count":39,"type":40},150,"ESTIMATED","OBSERVATIONAL","The Hip Disability and Osteoarthritis Outcome Score-12 (HOOS-12) is a short patient-reported outcome measure developed to assess pain, function, and hip-related quality of life in individuals with hip osteoarthritis. Although widely used internationally, a validated Turkish version is currently unavailable. This study aims to translate and culturally adapt the HOOS-12 into Turkish and evaluate its psychometric properties, including internal consistency, test-retest reliability, construct validity, structural validity, responsiveness, and measurement error, in Turkish-speaking patients with hip osteoarthritis.",[44],"Hip Osteoarthritis",[44,46,47,48],"validity","Turkish","Reliability","NOT_YET_RECRUITING","2026-08-17",{"date":52,"type":53},"2026-08-18","ACTUAL",{"date":55,"type":40},"2026-09-01",{"date":57,"type":40},"2027-12-01",{"name":5,"class":6}]